TriangleNCT05565638 · REGISTRY CONDITION SEARCH
PROFAST Intervention in Precursor Multiple Myeloma
Found through the registry condition index, not selected as a treatment recommendation. This discovery collection was restricted to studies with posted results.
- Phase
- NA
- Status at capture
- COMPLETED
- Registry last update
- 2026-10-07
This is a 4-month randomized trial of a prolonged nightly fasting intervention (PROFAST) in 40 overweight and obese individuals with monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM), and smoldering waldenstrom macroglobulinemia (SWM). The purpose of this study is to understand if fasting for a prolonged period of time during the nighttime hours is a strategy to prevent overweight and obese individuals from developing blood cancer. Participants will be randomized into the following two groups: * Group A: PROFAST intervention for 4 months * Group B: Healthy Lifestyle Control group for 4 months
Open the original ClinicalTrials.gov record → · Download preserved record
What did the study report?
Outcomes, safety and baseline populations are separate source sections. Quality-of-life measures appear under their original outcome titles.
Participant flow
Baseline characteristics
Changes in Body Composition (% Body Fat)
M-Protein Change by Serum Protein Electrophoresis and Serum Free Light Chain Assay
(M-)Protein Concentrations/Light Chains Change by Mass Spectrometry
Changes in Bone Marrow Adiposity
Changes in Plasma Metabolites Measured by Liquid Chromatography-mass Spectrometry
Adverse events
Limitations, agreements, and source contact
Who could take part
- eligibility Criteria
- Inclusion Criteria: * BMI \>= 25 kg/m2 * Documented diagnosis of MGUS or Smoldering MM(SMM) or Smoldering Waldenstrom Macroglobulinemia(WM) via EMR review. \*note: please review case with PI or treating MD if diagnosis is uncertain. * At least 18 years of age * Currently fasting for \<14 hours per night, as assessed using 24-hour food recalls * Owns a cell phone and is comfortable sending and receiving text messages * Ability to understand and the willingness to sign a written informed consent document Exclusion Criteria: * Diagnosis of overt MM or WM * Patients diagnosed with another malignancy requiring active therapy * Clinical diagnosis of diabetes, which may increase the risk of hypoglycemia with a prolonged fast. Note: patients with diabetes may enroll with consent from MD that manages their clinical care. * Any other condition that, in the investigator's judgment, would contraindicate prolonged nightly fasting or otherwise interfere with participation in the trial, including night shift work, night eating syndrome, taking weight loss medication, or participation in another weight loss program
- healthy Volunteers
- false
- minimum Age
- 18 Years
- sex
- ALL
- std Ages
- ADULT
- OLDER_ADULT
Treatment arms and interventions
- arm Groups
- description
- The prolonged nightly fasting (PROFAST) intervention involves gradually working up to a 14-hour fast during the nighttime hours. Participants will be supported by means of calls with a health coach during the first 4 weeks of the study. Participants will also be asked to use a text messaging platform to record their first and last meal of the day, and will receive personalized feedback based on the meal times they record via the text messaging system. The text messaging system will be used throughout the duration of the study.
- intervention Names
- Behavioral: Prolonged Fasting Intervention
- label
- PROLONGED FASTING INTERVENTION
- type
- EXPERIMENTAL
- description
- For participants randomized to the control group, an introductory session with a health coach and educational information will be provided. Participants will also receive one email and one text message per week with tips on healthy living during the 4 months of the study
- intervention Names
- Behavioral: EDUCATION CONTROL
- label
- EDUCATION CONTROL
- type
- ACTIVE_COMPARATOR
- interventions
- arm Group Labels
- PROLONGED FASTING INTERVENTION
- description
- promote a 14-hour fast during the nighttime hours
- name
- Prolonged Fasting Intervention
- type
- BEHAVIORAL
- arm Group Labels
- EDUCATION CONTROL
- description
- introductory session with a health coach and educational information will be provided. Participants will also receive one email and one text message per week with tips on healthy living
- name
- EDUCATION CONTROL
- type
- BEHAVIORAL
Study design
- allocation
- RANDOMIZED
- intervention Model
- PARALLEL
- masking Info
- masking
- NONE
- primary Purpose
- PREVENTION
Enrollment
- count
- 23
- type
- ACTUAL
Registered outcome plans (not posted results)
- primary Outcomes
- description
- assessed via whole body DXA scans
- measure
- Changes in Body Composition (% Body Fat)
- time Frame
- baseline to 4-months
- secondary Outcomes
- description
- Monoclonal (M-)proteins produced in excess by an abnormal clonal proliferation of plasma (MM) cells that can be measured in the serum using Serum Protein Electrophoresis (SPEP) and the Serum Free Light Chain Assay.
- measure
- M-Protein Change by Serum Protein Electrophoresis and Serum Free Light Chain Assay
- time Frame
- baseline to 4-months
- measure
- (M-)Protein Concentrations/Light Chains Change by Mass Spectrometry
- time Frame
- Baseline to 4-months
- measure
- Changes in Bone Marrow Adiposity
- time Frame
- Baseline to 4-months
- measure
- Changes in Plasma Metabolites Measured by Liquid Chromatography-mass Spectrometry
- time Frame
- Baseline to 4-months
Full study description
- brief Summary
- This is a 4-month randomized trial of a prolonged nightly fasting intervention (PROFAST) in 40 overweight and obese individuals with monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM), and smoldering waldenstrom macroglobulinemia (SWM). The purpose of this study is to understand if fasting for a prolonged period of time during the nighttime hours is a strategy to prevent overweight and obese individuals from developing blood cancer. Participants will be randomized into the following two groups: * Group A: PROFAST intervention for 4 months * Group B: Healthy Lifestyle Control group for 4 months
- detailed Description
- The purpose of this research study is to learn if fasting for a prolonged period of time could be used in the future to help improve body composition and prevent blood cancer in overweight and obese individuals with MGUS, SMM, and SWM. Multiple myeloma is a cancer of the plasma cells, which is an important part of the immune system. Participants with active multiple myeloma generally require treatment. There are currently no approved therapies or prevention strategies for smoldering multiple myeloma or monoclonal gammopathy of undetermined significance. The National Cancer Institute of the National Institutes of Health is supporting this research study by providing funding. This research study is a 4-month randomized trial of prolonged nightly fasting (PROFAST). It is expected that about 40 people will take part in this research study. The total study duration is 4 months. Participants in the study will be randomized, in equal numbers to either the nightly fasting intervention group or a control group. * The prolonged nightly fasting (PROFAST) intervention involves gradually working up to a 14-hour fast during the nighttime hours. Participants will be supported by means of calls with a health coach during the first 4 weeks of the study. Participants will also be asked to use a text messaging platform to record their first and last meal of the day, and will receive personalized feedback based on the meal times via the text messaging system. The text messaging system will be used throughout the duration of the study. * For participants randomized to the control group, an introductory session with a health coach and educational information will be provided. Participants will also receive one email and one text message per week with tips on healthy living during the 4 months of the study.
Source references
- references
- citation
- Lee DJ, O'Donnell EK, Raje N, Panaroni C, Redd R, Ligibel J, Sears DD, Nadeem O, Ghobrial IM, Marinac CR. Design and Rationale of Prolonged Nightly Fasting for Multiple Myeloma Prevention (PROFAST): Protocol for a Randomized Controlled Pilot Trial. JMIR Res Protoc. 2024 Mar 11;13:e51368. doi: 10.2196/51368.
- pmid
- 38466984
- type
- DERIVED
Source notices and limitations
Discovery and provenance
- release id
- ctgov-registry-ed65b07fb707529eef6b84b3
- edge id
- nct-edge-08bb271fc4ca2f12675a
- requested nct id
- NCT05565638
- primary nct id
- NCT05565638
- source kind
- ctgov_condition_query
- source record id
- Source null
- source file sha256
- eb89f9d2b7bdc4723e476a17de44ec4c2c2f3319679460875d6894d4041313ef
- payload sha256
- 530f735d4c533f0cbcfe190733fc761f382564f0f3a06bc6be882ff669c57355
- payload
- clinical indication matching status
- condition_index_match_asserted_by_registry_not_reviewed
- end exclusive
- true
- id
- nct-edge-08bb271fc4ca2f12675a
- link basis
- returned_by_explicit_condition_and_posted_results_filter_query
- nct id
- NCT05565638
- occurrences
- context exact
- NCT05565638
- end
- 11
- exact text
- NCT05565638
- start
- 0
- offset unit
- unicode_code_points
- query cond
- Plasma Cell Neoplasms
- query disease state id
- ds-plasma-cell-neoplasms
- source file
- /Users/arunverma/Documents/ChatGPT/Cancer Statistics Website/research-data/2026-10-20/clinicaltrials-condition/round-0000/raw/cond-plasma-cell-neoplasms-000.json
- source file sha256
- eb89f9d2b7bdc4723e476a17de44ec4c2c2f3319679460875d6894d4041313ef
- source json pointer
- /studies/513/protocolSection/identificationModule/nctId
- source kind
- ctgov_condition_query
- source record id
- Source null
- source string basis
- parsed_JSON_string_unmodified
- source string sha256
- f17c96e43101abba6d17d37e8f23bd7423468f35b454a7ce3df0aa307fec8056
Preserved source evidence · Not medical advice